Cancer patients could stand to benefit from Quingong , a form of traditional Chinese medication- it is a 5000-year-old combination of gentle exercise and meditation.
Those practicing it experienced significantly higher wellbeing levels, improved cognitive functioning and less inflammation compared to a control group, new University of Sydney research has found.Dr Byeongsang Oh, a clinical senior lecturer at the Sydney Medical School who led the study, said the reduced inflammation in patients who practiced medical Qigong, a form of traditional Chinese medicine, was particularly significant.
"Several studies have indicated chronic inflammation is associated with cancer incidence, progression and even survival," says Dr Oh, who will present his findings to the American Society of Clinical Oncology (ASCO) conference in Chicago next week. Those practicing it experienced significantly higher wellbeing levels, improved cognitive functioning and less inflammation compared to a control group, new University of Sydney research has found.Dr Byeongsang Oh, a clinical senior lecturer at the Sydney Medical School who led the study, said the reduced inflammation in patients who practiced medical Qigong, a form of traditional Chinese medicine, was particularly significant.
"Patients who practiced medical Qigong experienced significant improvements in quality of life, including greater physical, functional, social and emotional wellbeing, and enhanced cognitive functioning, while the control group deteriorated in all of these areas," Dr Oh says.
He also found the patients in the medical Qigong group reported increased satisfaction with their sex lives.
The study involved 162 patients, with those assigned to the medical Qigong group undertaking a ten-week program of two supervised 90-minute sessions per week. They were also encouraged to practise at home every day for at least half an hour.
The mean age of participants in this study was 60, with ages ranging from 31 to 86 years. The most common primary cancer diagnosis among participants was breast cancer (34 percent) followed by colorectal cancer (12 percent).
No comments:
Post a Comment